Sign In
Buy ADMA
$8.69
+0.120 (+1.40%)
At Close: Jun 23, 2026
Adma Biologics (ADMA) Stock Sinks As Market Gains: Here's Why
06:56pm, Tuesday, 14'th Jan 2025
The latest trading day saw Adma Biologics (ADMA) settling at $16.32, representing a -1.03% change from its previous close.
ADMA Stock Catapults 275.7% in a Year: How Should You Play the Stock?
02:45pm, Friday, 10'th Jan 2025
ADMA Biologics performance in the past twelve months has been phenomenal. While the prospects remain sound, the exceptional rally witnessed by the stock might limit any further gain.
Adma Biologics (ADMA) Surpasses Market Returns: Some Facts Worth Knowing
07:11pm, Wednesday, 08'th Jan 2025
Adma Biologics (ADMA) closed at $18.56 in the latest trading session, marking a +1.48% move from the prior day.
Is It Worth Investing in Adma Biologics (ADMA) Based on Wall Street's Bullish Views?
10:41am, Wednesday, 08'th Jan 2025
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often
4 Drug, Biotech Stocks Rising More Than 50% in 2024 With Room to Grow
12:51pm, Tuesday, 24'th Dec 2024
Here, we discuss four biotech stocks, ADMA, TARS, STOK and CDXC, which have returned more than 50% year to date and have room for more growth in 2025.
ADMA Biologics Announces Partial Paydown of Senior Term Loan Credit Facility
07:00am, Friday, 20'th Dec 2024
Cash on Hand Utilized to Repay $30 Million of Senior Secured Term Loan Facility to Ares Capital Lowers ADMA's Total Debt to $75 Million, a 29% Reduction Further Supports Earnings Growth Outlook RAMSEY
4 Biotech Stocks Most Wall Street Analysts Are Bullish About
02:25pm, Thursday, 19'th Dec 2024
Here, we present four biotech stocks, namely SRPT, ADMA, EXEL and ALNY, which most Wall Street analysts are optimistic about. These companies have upside potential for 2025, backed by strong fundament
LOS ANGELES, CA / ACCESSWIRE / December 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ADMA Biologic
The Schall Law Firm Invites Shareholder Participation In An Inquiry Into ADMA Biologics Inc For Securities Law Violations
05:45pm, Thursday, 12'th Dec 2024
LOS ANGELES, CA / ACCESSWIRE / December 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ADMA Biologic
ADMA Biologics, Inc. Is Being Investigated For Securities Fraud And Investors With Losses Are Encouraged To Contact The Schall Law Firm
06:15pm, Wednesday, 11'th Dec 2024
LOS ANGELES, CA / ACCESSWIRE / December 11, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ADMA Biologic
The Schall Law Firm Urges Shareholder Contributions To An Inquiry Into ADMA Biologics Inc's Possible Securities Law Violations
05:30pm, Tuesday, 10'th Dec 2024
LOS ANGELES, CA / ACCESSWIRE / December 10, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ADMA Biologic
ADMA Stock Falls 19% From Its 52-Week High: Should You Buy the Dip?
02:15pm, Tuesday, 10'th Dec 2024
ADMA Biologics has performed phenomenally in 2024. Given its strong trajectory, we recommend investors use any dip in the stock price as a buying opportunity.
LOS ANGELES, CA / ACCESSWIRE / December 9, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ADMA Biologics
The Schall Law Firm Urges Stockholders To Join An Inquiry Into ADMA Biologics Inc's Possible Securities Law Violations
05:15pm, Sunday, 08'th Dec 2024
LOS ANGELES, CA / ACCESSWIRE / December 8, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ADMA Biologics
ADMA Biologics, Inc. Is Being Investigated For Fraud And Investors With Losses Are Invited To Reach Out To The Schall Law Firm
05:30pm, Saturday, 07'th Dec 2024
LOS ANGELES, CA / ACCESSWIRE / December 7, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ADMA Biologics
